Paris, France

Jerome Wojcik

This inventor holds 1 USPTO granted patent. Top assignee: Hybrigenics. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerome Wojcik. Retrieved from https://idiyas.com/inventor/jerome-wojcik-4pn8g04s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerome Wojcik: Innovator in Hepatitis C Research

Introduction

Jerome Wojcik is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the study of hepatitis C virus.

Latest Patents

Wojcik holds a patent for "Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof." This invention relates to nucleic acids encoding SID® polypeptides that selectively bind to a polypeptide encoded by a pathogenic strain of the hepatitis C virus. The patent also includes vectors comprising a nucleic acid encoding a SID® polypeptide and host cells transformed with such vectors. Additionally, it covers two-hybrid methods utilizing the nucleic acids encoding SID® polypeptides and methods for selecting molecules that inhibit the binding between a SID® polypeptide and its specific binding partner.

Career Highlights

Wojcik is associated with Hybrigenics, a company known for its innovative approaches in the field of biotechnology. His work has been instrumental in advancing research related to hepatitis C.

Collaborations

He has collaborated with notable colleagues such as Pierre Legrain and Simon Whiteside, contributing to various projects and research initiatives.

Conclusion

Jerome Wojcik's contributions to hepatitis C research through his innovative patents and collaborations highlight his role as a significant figure in biotechnology. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…